LIANY — LianBio Balance Sheet
0.000.00%
HealthcareAdventurousMicro Cap
- $21.43m
- -$197.01m
Annual balance sheet for LianBio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Cash and Equivalents | ||||
Short Term Investments | ||||
Cash and Short Term Investments | 43.3 | 254 | 383 | 302 |
Net Total Receivables | 0.047 | 21.3 | 7.22 | 4.41 |
Prepaid Expenses | ||||
Total Other Current Assets | ||||
Total Current Assets | 43.3 | 277 | 400 | 313 |
Gross Property, Plant And Equipment | ||||
Accumulated Depreciation | ||||
Net Property, Plant And Equipment | 0.532 | 2.53 | 6.64 | 7.09 |
Other Long Term Assets | ||||
Total Assets | 43.9 | 279 | 426 | 320 |
Accounts Payable | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 3.35 | 6.23 | 15.1 | 23.6 |
Total Long Term Debt | ||||
Total Debt | ||||
Minority Interest | ||||
Total Other Liabilities | ||||
Total Liabilities | 4.69 | 62.3 | 72.8 | 60.1 |
Redeemable Preferred Stock | ||||
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
Other Equity | ||||
Total Equity | 39.2 | 217 | 354 | 260 |
Total Liabilities & Shareholders' Equity | 43.9 | 279 | 426 | 320 |
Total Common Shares Outstanding |